Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for X4 Pharmaceuticals (XFOR) over the last 7 years, with Q3 2025 value amounting to 0.25.

  • X4 Pharmaceuticals' Asset Utilization Ratio rose 428303.25% to 0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25, marking a year-over-year increase of 428303.25%. This contributed to the annual value of 0.02 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, X4 Pharmaceuticals' Asset Utilization Ratio stood at 0.25, which was up 428303.25% from 0.28 recorded in Q2 2025.
  • X4 Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.28 during Q2 2025, with a 5-year trough of 0.03 in Q1 2023.
  • In the last 4 years, X4 Pharmaceuticals' Asset Utilization Ratio had a median value of 0.01 in 2022 and averaged 0.04.
  • As far as peak fluctuations go, X4 Pharmaceuticals' Asset Utilization Ratio crashed by 25526.86% in 2023, and later skyrocketed by 790041.21% in 2025.
  • Over the past 4 years, X4 Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.03 in 2022, then soared by 76.69% to 0.01 in 2023, then skyrocketed by 331.51% to 0.02 in 2024, then soared by 1480.69% to 0.25 in 2025.
  • Its last three reported values are 0.25 in Q3 2025, 0.28 for Q2 2025, and 0.23 during Q1 2025.